Conditions

Novartis Summit: Stroke, leading cause of preventable deaths in adults – Prof. Ogun

L-R Dr. Anyiam Chinasaokwu, Prof. Omotoso and Prof. Michael Balogun at the Novartis Summit

Novartis Summit: Consultant Physician/Neurologist at the Lagos State University College of Medicine/Lagos State University Teaching Hospital (LASUCOM/LASUTH), Prof. Yomi Ogun, has called for more proactive efforts to optimize stroke prevention, noting that the condition is now a leading cause of preventable deaths in adults globally.

Ogun, who delivered a paper on “Stroke Management in Nigeria – The Role of Cross Functional Specialties” at the 2018 Novartis International Cardiovascular Summit which was held recently at the Lagos Continental Hotel, Victoria Island, lamented that management of stroke  patients in Nigeria and Africa is still less than optimal, as stroke units are not yet developed and neuro-imaging centers are very few.

This, he said, is a major reason why access to treatment for heart failure is seriously limited by cost and distance.

He disclosed further that 1 in 6 individuals will have stroke in their lifetime, adding that the lifetime risk of stroke is 1 in 5 women and 1 in 6 men.

Prof.-Omotoso-and-Prof.-Yomi-Ogun-at-the-Novartis-Summit

The renowned physician equally bemoaned the fact that it is difficult to build a multidisciplinary rehabilitation team for the management of stroke patients in the country due to the dearth of paramedical staff, physiotherapists, occupational therapists and stroke nurses.

While stressing that the most important strategy for stroke treatment is modification of lifestyle and risk factors, Ogun reiterated that what patients deserve is timely access to quality services that are appropriate to their needs.

Research, he disclosed, has shown that proper care of stroke patients must start with a reorganization of the entire stroke chain – from the pre-hospital scene, through the emergency room to the stroke unit, adding that without a structured stroke service, no pharmacological or intervening therapy is likely to improve the outcome.

This is a SPONSORED POST from the Novartis Summit.

(Visited 9 times, 1 visits today)
Facebooktwittergoogle_pluslinkedinrssyoutubeby feather
Facebooktwittergoogle_plusredditpinterestlinkedinmailby feather